Molecule Details
InChIKeyCOKMIXFXJJXBQG-NRFANRHFSA-N
Compound NameTirofiban
Canonical SMILESCCCCS(=O)(=O)N[C@@H](Cc1ccc(OCCCCC2CCNCC2)cc1)C(=O)O
Clinical Status Data-mined Candidate
Targets (Human+Pathogen)4
Pfam Stratification Cross-Family
Avg pChEMBL7.88
SourceBindingDB;ChEMBL
2D Structure
2D structure
Activity Profile
DrugBank Annotations
DrugBank ID DB00775
Drug NameTirofiban
CAS Number144494-65-5
Groups approved investigational
ATC Codes B01AC17
DescriptionTirofiban prevents the blood from clotting during episodes of chest pain or a heart attack, or while the patient is undergoing a procedure to treat a blocked coronary artery. It is a non-peptide reversible antagonist of the platelet glycoprotein (GP) IIb/IIIa receptor, and inhibits platelet aggregat...

Categories: Amino Acids Amino Acids, Aromatic Amino Acids, Cyclic Amino Acids, Peptides, and Proteins Antiplatelet agents Blood and Blood Forming Organs Cardiovascular Agents Decreased Platelet Aggregation Drugs that are Mainly Renally Excreted Fibrin Modulating Agents Hematologic Agents Platelet Aggregation Inhibitors Excl. Heparin
Cross-references: BindingDB: 50004058 ChEBI: 9605 CHEMBL916 ChemSpider: 54912 Drugs Product Database (DPD): 11752 C07965 PDB: AGG PharmGKB: PA451698 PubChem:60947 PubChem:46504678 RxCUI: 73137 Therapeutic Targets Database: DAP000696 Wikipedia: Tirofiban ZINC: ZINC000003806104
Target Activities (4)
Target Gene Organism Category Pfam pChEMBL Type Source
P08514 ITGA2B Homo sapiens Human PF01839 PF08441 PF20805 PF20806 PF00357 8.1 IC50 ChEMBL;BindingDB
P05106 ITGB3 Homo sapiens Human PF07974 PF23105 PF18372 PF08725 PF07965 PF00362 PF17205 8.0 IC50 ChEMBL;BindingDB
P06756 ITGAV Homo sapiens Human PF01839 PF08441 PF20805 PF20806 PF00357 8.0 IC50 ChEMBL
P17301 ITGA2 Homo sapiens Human PF01839 PF20805 PF20806 PF00092 7.5 IC50 BindingDB
DrugBank Target Actions (2)
Target Gene Target Name Action Type
P05106 ITGB3 Integrin beta-3 antagonist targets
P08514 ITGA2B Integrin alpha-IIb antagonist targets